Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty analysis from the RECORD trials

Thrombosis and Haemostasis

Volumn 107, Issue 2, 2012, Pages 225-231

  Cohn, Danny M ^a   Hermanides, Jeroen ^a   Hans de vries, J ^a   Kamphuisen, Pieter Willem ^b   Kuhls, Silvia ^c   Homering, Martin ^c   Hoekstra, Joost B L ^a   Lensing, Anthonie W A ^a,c   Büller, Harry R ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c BAYER PHARMA AG   (Germany)

Author keywords

Arthroplasty; Deep venous thrombosis; Hyperglycaemia; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ADULT; AGE; AGED; ARTHROPLASTY; ARTICLE; BODY MASS; COMPARATIVE STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); PHLEBOGRAPHY; POST HOC ANALYSIS; PRIORITY JOURNAL; STRESS INDUCED HYPERGLYCEMIA; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CLINICAL TRIALS, PHASE III AS TOPIC; COHORT STUDIES; FEMALE; GLUCOSE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PHLEBOGRAPHY; POSTOPERATIVE COMPLICATIONS; STRESS, PSYCHOLOGICAL; SURVIVAL ANALYSIS; VENOUS THROMBOEMBOLISM;

EID: 84856680948     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-07-0447     Document Type: Article

References (27)

1. Naess IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5: 692-699.
2. Lensing AW, Prandoni P, Prins MH, et al. Deep-vein thrombosis. Lancet 1999; 353: 479-485.
3. Spencer FA, Emery C, Lessard D, et al. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med 2006; 21: 722-727.
4. Stegenga ME, van der Crabben SN, Levi M, et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes 2006; 55: 1807-1812.
5. Stegenga ME, van der Crabben SN, Blumer RM, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 2008; 112: 82-89.
6. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet 2009; 373: 1798-1807.
7. Hermanides J, Huijgen R, Henny CP, et al. Hip surgery sequentially induces stress hyperglycaemia and activates coagulation. Neth J Med 2009; 67: 226-229.
8. Hermanides J, Cohn DM, Devries JH, et al. Venous thrombosis is associated with hyperglycemia at diagnosis: a case-control study. J Thromb Haemost 2009; 7: 945-949.
9. Galster H, Kolb G, Kohsytorz A, et al. The pre-, peri-, and postsurgical activation of coagulation and the thromboembolic risk for different risk groups. Thromb Res 2000; 100: 381-388.
10. Warwick D, Friedman RJ, Agnelli G, et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. J Bone Joint Surg Br 2007; 89: 799-807.
11. Eriksson BI, Borris LC, Friedman RJ, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008; 358: 2765-2775.
12. Kakkar AK, Brenner B, Dahl OE, et al. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 2008; 372: 31-39.
13. Lassen MR, Ageno W, Borris LC, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 2008; 358: 2776-2786.
14. Turpie AG, Lassen MR, Davidson BL, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet 2009; 373: 1673-1680.
15. Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 1972; 104: 134-144.
16. Mraovic B, Hipszer BR, Epstein RH, et al. Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery. J Arthroplasty 2010; 25: 64-70.
17. Marchant MH, Jr., Viens NA, Cook C, et al. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am 2009; 91: 1621-1629.
18. Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 2001; 15: 44-54.
19. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31 (Suppl 1): S55-S60.
20. Sharrock NE, Go G, Sculco TP, et al. Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquet. J Arthroplasty 1995; 10: 523-528.
21. Parmet JL, Horrow JC, Pharo G, et al. The incidence of venous emboli during extramedullary guided total knee arthroplasty. Anesth Analg 1995; 81: 757-762.
22. Parmet JL, Horrow JC, Berman AT, et al. The incidence of large venous emboli during total knee arthroplasty without pneumatic tourniquet use. Anesth Analg 1998; 87: 439-444.
23. Westman B, Weidenhielm L, Rooyackers O, et al. Knee replacement surgery as a human clinical model of the effects of ischaemia/reperfusion upon skeletal muscle. Clin Sci 2007; 113: 313-318.
24. Carles M, Dellamonica J, Roux J, et al. Sevoflurane but not propofol increases interstitial glycolysis metabolites availability during tourniquet-induced ischaemiareperfusion. Br J Anaesth 2008; 100: 29-35.
25. Kehlet H, Brandt MR, Hansen AP, et al. Effect of epidural analgesia on metabolic profiles during and after surgery. Br J Surg 1979; 66: 543-546.
26. Lattermann R, Belohlavek G, Wittmann S, et al. The anticatabolic effect of neuraxial blockade after hip surgery. Anesth Analg 2005; 101: 1202-1208.
27. Schricker T, Carvalho G, Meterissian S. Epidural combined with propofol anesthesia does not suppress the hyperglycemic response to abdominal surgery. Can J Anaesth 2005; 52: 652.